SCHEMBL458246

SCHEMBL458246

O=C1C(=NNC(=S)NCc2ccccc2)Nc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.49
GAA P10253 5/20 0.49
ALOX12 P18054 6/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 5/20 0.45
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
POLB P06746 1/20 0.45
TDP1 Q9NUW8 6/20 0.44
LMNA P02545 5/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PKM P14618 1/20 0.42
HTT P42858 3/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MITF O75030 1/20 0.41
PLA2G1B P04054 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455445 0.81 ALDH1A1 (0.42) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL456344 0.77 KMT2A (0.50) ALDH1A1GAAHPGDSMN1; SMN2MAPT
SCHEMBL457313 0.77 TDP1 (0.56) ALDH1A1GAAALOX12HPGDSMN1; SMN2
SCHEMBL455238 0.76 RAB9A (0.44) ALDH1A1GAAHPGDSMN1; SMN2MAPT
SCHEMBL456579 0.75 ALDH1A1 (0.51) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL2877863 0.74 ALDH1A1 (0.46) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL2877739 0.74 MAPT (0.51) ALDH1A1GAAALOX12HPGDSMN1; SMN2
SCHEMBL455180 0.73 EPHX1 (0.44) ALDH1A1GAAALOX12HPGDSMN1; SMN2
SCHEMBL457447 0.72 MAOA (0.34) ALDH1A1GAASMN1; SMN2MAPTKMT2A
SCHEMBL456638 0.72 MAOA (0.34) ALDH1A1GAAALOX12SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
EP-2240175-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services (US) 2010-10-20 EP disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed